COVID-19 Pediatric Dermatology

Holly Neale1, Elena B Hawryluk2

  • 1Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA; University of Massachusetts Medical School, Worcester, MA, USA.

Dermatologic Clinics
|September 24, 2021
PubMed

Insights

Pediatric COVID-19 skin manifestations can be the sole indicator of infection. Recognizing these unique dermatologic signs is crucial for timely diagnosis and management in children.

Area of Science:

  • Pediatric Infectious Diseases
  • Dermatology
  • Public Health

Background:

  • Children exhibit distinct COVID-19 presentations, often asymptomatic or mild.
  • Cutaneous manifestations can be the primary or sole sign of infection in pediatric cases.
  • Understanding these skin signs is vital for infection control and patient management.

Purpose of the Study:

  • To describe the presentation of skin manifestations in children with COVID-19.
  • To review pathophysiologic theories behind pediatric COVID-19 dermatologic findings.
  • To outline management strategies for cutaneous manifestations of COVID-19 in children.

Main Methods:

  • Literature review of pediatric COVID-19 cases with dermatologic involvement.
  • Analysis of reported skin lesion types and frequencies in children.
  • Synthesis of current understanding of viral-skin interactions in pediatric SARS-CoV-2 infection.

Main Results:

  • Pediatric COVID-19 skin findings range from common viral exanthems to specific patterns like chilblains.
  • Some dermatologic signs in children differ in frequency or presentation compared to adults.
  • Cutaneous signs may indicate broader systemic involvement or sequelae.

Conclusions:

  • Cutaneous manifestations are significant indicators of COVID-19 in children.
  • Early recognition of pediatric skin signs aids in prompt diagnosis and public health measures.
  • Further research into the pathophysiology and long-term implications of these findings is warranted.

Related Concept Videos

Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.5K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31